Ebola virus: A clear and present danger

Journal of Clinical Microbiology

Volumn 53, Issue 1, 2015, Pages 4-8

  Burd, Eileen M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; BACTERIAL TRANSMISSION; DIAGNOSTIC KIT; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EMERGENCY CARE; EPIDEMIC; GUINEA; HEALTH CARE FACILITY; HIGH RISK PATIENT; HOSPITAL CARE; HUMAN; LABORATORY; LIBERIA; POLYMERASE CHAIN REACTION SYSTEM; REVIEW; SANITATION; SIERRA LEONE; UNITED STATES; ANIMAL; CLASSIFICATION; EBOLAVIRUS; GENETICS; HEALTH SURVEY; HEMORRHAGIC FEVER, EBOLA; MICROBIOLOGICAL EXAMINATION; PROCEDURES; TRANSMISSION;

EBOLA VIRUS;

AFRICA, WESTERN; ANIMALS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MICROBIOLOGICAL TECHNIQUES; POPULATION SURVEILLANCE;

EID: 84919498413     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03115-14     Document Type: Review

References (25)

1. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Dániel Cadar D, Gabriel M, Pahlmann M, Tappe D, Jonas Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S. 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371:1418-1425. http://dx.doi.org/10.1056 /NEJMoa1404505.
2. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:1369-1372. http://dx.doi.org/10.1126/science.1259657.
3. Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML. 2014. Estimating the future number of cases in the Ebola epidemic-Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ 63(Suppl 3):1-14.
4. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, Kawaoka Y, Lipkin WI, Negredo AI, Netesov SV, Nichol ST, Palacios G, Peters CJ, Tenorio A, Volchkov VE, Jahrling PB. 2010. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 155:2083-2103. http://dx.doi .org/10.1007/s00705-010-0814-x.
5. Centers for Disease Control. 1988. Management of patients with suspected viral hemorrhagic fever.MMWRMorb Mortal Wkly Rep 37:1-16.
6. Public Health Agency of Canada. 22 August 2014. Pathogen safety data sheet. Ebolavirus. Public Health Agency of Canada, Ottawa, Canada. http: //www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/ebola-eng.php.
7. World Health Organization. 2014. Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf.
8. Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. 2010. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 109:1531-1539. http://dx.doi.org/10.1111/j .1365-2672.2010.04778.x.
9. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, Nichol ST, Ksiazek TG, Rollin PE. 2007. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 196:S142-S147. http://dx.doi.org/10.1086/520545.
10. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM, Jr. 1997. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399-411. http://dx.doi.org/10.1001/jama.1997.03550050061035.
11. Ansari AA. 14 September 2014. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun http://dx.doi.org/10.1016/j.jaut.2014 .09.001.
12. Leroy EM, Baize S, Lu CY, McCormick JB, Georges AJ, Georges-Courbot MC, Lansoud-Soukate J, Fisher-Hoch SP. 2000. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 60: 463- 467. http://dx.doi.org/10.1002/(SICI)1096-9071(200004)60:4<463::AID-JMV15>3.0.CO;2-M.
13. Wong G, Kobinger GP, Qiu X. 2014. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol 10:781-790. http://dx.doi.org/10.1586/1744666X.2014.908705.
14. MacNeil A, Reed Z, Rollin PE. 2011. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis 5:e1175. http://dx.doi.org/10.1371/journal.pntd.0001175.
15. Sobarzo A, Ochayon DE, Lutwama JJ, Balinandi S, Guttman O, Marks RS, Kuehne AI, Dye JM, Yavelsky V, Lewis EC, Lobel L. 2013. Persistent immune responses after Ebola virus infection.NEngl J Med 369:492-493. http://dx.doi.org/10.1056/NEJMc1300266.
16. Saijo M, Niikura M, Ikegami T, Kurane I, Kurata T, Morikawa S. 2006. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol 13:444-451. http://dx.doi.org/10.1128/CVI.13.4.444-451.2006.
17. Johnson KM, Webb PA, Larige VE, Murphy FA. 1977. Isolation and partial characterization of a new virus causing acute hemorrhagic fever in Zaire. Lancet i:569-571.
18. El Mekki AA, Van Der Groen G. 1981. A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhagic viruses in cell cultures. J Virol Methods 3:61-69. http://dx.doi.org/10.1016/0166-0934(81)90002-1.
19. Stroher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H. 2001. Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 75:11025-11033. http://dx.doi.org/10.1128/JVI.75.22.11025-11033.2001.
20. Gibb TR, Norwood DA, Jr, Woollen N, Henchal EA. 2002. Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain). Clin Diagn Lab Immunol 9:19-27. http://dx.doi.org/10.1128/CDLI.9.1.19-27.2002.
21. Lucht A, Grunow R, Otterbein C, Möller P, Feldmann H, Becker S. 2004. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol 193:181-187. http://dx.doi.org/10.1007/s00430-003-0204-z.
22. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, Kaducu F, Downing R, Nichol ST. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78:4330-4341. http://dx.doi.org/10.1128/JVI.78.8.4330-4341.2004.
23. Leroy EM, Baize S, Mavoungou E, Apetrei C. 2002. Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. J Gen Virol 83:67-73.
24. Drosten C, Kümmerer BM, Schmitz H, Günther S. 2003. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res 57:61-87. http://dx.doi.org/10.1016/S0166-3542(02)00201-2.
25. Panning M, Laue T, Ölschlager S, Eickmann M, Becker S, Raith S, Courbot MG, Nilsson M, Gopal R, Lundkvist A, di Caro A, Brown D, Meyer H, Lloyd G, Kümmerer BM, Günther S, Drosten C. 2007. Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis 196:S199-S204. http://dx.doi.org/10.1086/520600.